• Explore /
  • Poster
  • / ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

Abstract Video & Slides Poster

Authors

null

David Sebag-Montefiore

University of Leeds, Leeds, United Kingdom

David Sebag-Montefiore , Richard Adams , Simon Gollins , Leslie M. Samuel , Robert Glynne-Jones , Robert Harte , Nicholas West , Philip Quirke , Arthur Sun Myint , Simon P Bach , Philip Parsons , Stephen Falk , Amandeep Singh Dhadda , Vivek Misra , Nick Brown , Gina Brown , Mark Harrison , Laura White , Marian Duggan , Andre Lopes

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

09351447

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4101)

DOI

10.1200/JCO.2020.38.15_suppl.4101

Abstract #

4101

Poster Bd #

93

Abstract Disclosures

Similar Posters

First Author: Ji Zhu

Poster

2021 Gastrointestinal Cancers Symposium

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.

First Author: Wen Zhang

First Author: Zhen Zhang

First Author: Jun Watanabe